Business
GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits
GB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences: Develops Extremely High THC Content Cannabis Strain With Maximized Terpene Levels To Increase Medical Benefits\nThree Complementary Operating Units Produce an Important Genetic Strain\nPR Newswire\nLAS VEGAS, Dec. 13, 2017\n\n\n\nLAS VEGAS, Dec. 13, 2017 /PR Newswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is proud to announce its development of a cannabis strain that has an extremely high THC concentration, and also has a specifically-defined terpene profile, meaning that this potent strain may have significant medical benefits.\n\n\n \n  \n\n \nThe team was gratified to receive hard test results that verified their goal. The plant produced a THC-a content of 35.119%, as well as β-myrcene levels of 2.18% and β-caryophyllene levels of 1.01%, as tested by independent lab Digipath Labs, Inc. in Las Vegas. \n\n\"Because of our research background, we're not willing to talk about things while we have only anecdotal evidence. But now, we have solid data that shows that the innovations that we have been working on for years are starting to bear fruit,\" said Chief Science Office, Dr. Andrea Small-Howard.\n\nThis strain is the result of an ongoing research project and is one of many tangible results of the coordination of the three operating units--- Life Sciences, Tissue Propagation, and Cultivation Labs.  GB Sciences is a fully integrated cannabis company with three complementary operating units. The internal pipeline is now fully solidified; the Life Sciences division researches and develops the profile for a strain that is thought to be medicinally important; the Tissue Propagation team acquires the specified genetics and begins the propagation process to provide clean, healthy, starter plants so that verifiable and consistent results can be gained;  the new plants then move into the Cultivation Labs precision controlled growing environment and are matured under s...